Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07537049
What this trial is testing

BR101 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 10
Testing effectiveness (Phase 2)Study completedNCT02375555
What this trial is testing

Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 40
Not applicableStudy completedNCT06504524
What this trial is testing

Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US

Who this might be right for
Multiple Myeloma
Pfizer 633
Not applicableStudy completedNCT03506386
What this trial is testing

Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis

Who this might be right for
Multiple Myeloma
Takeda 943
Large-scale testing (Phase 3)Not Yet RecruitingNCT07740486
What this trial is testing

A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease

Who this might be right for
Multiple Myeloma (MM)
Polish Myeloma Consortium 248
Early research (Phase 1)Not Yet RecruitingNCT06435910
What this trial is testing

Engineered Dendritic Cell Vaccines for Multiple Myeloma

Who this might be right for
Multiple Myeloma or Plasmacytoma
Shenzhen Geno-Immune Medical Institute 10
Not applicableStudy completedNCT05932290
What this trial is testing

Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 514
Not applicableEnded earlyNCT01927718
What this trial is testing

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT05032820
What this trial is testing

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Medical College of Wisconsin 40
Early research (Phase 1)Ended earlyNCT04887259
What this trial is testing

Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple MyelomaAcute Myeloid Leukemia
Lava Therapeutics 16
Testing effectiveness (Phase 2)Looking for participantsNCT07585760
What this trial is testing

CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Who this might be right for
Multiple Myeloma (MM)Multiple Myeloma Light Chain Induced Renal Insufficiency
Institute of Hematology & Blood Diseases Hospital, China 26
Not applicableLooking for participantsNCT05530096
What this trial is testing

Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD

Who this might be right for
Multiple Myeloma
Sir Mortimer B. Davis - Jewish General Hospital 70
Early research (Phase 1)WithdrawnNCT02658396
What this trial is testing

GO-203-2C + Bortezomib For Relapsed Or Refractory MM

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseRefractory Multiple Myeloma
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT03700450
What this trial is testing

Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 37
Not applicableNot Yet RecruitingNCT07045168
What this trial is testing

Risk-adapted Therapeutic Strategy in +1q NDMM

Who this might be right for
Multiple Myeloma
FengYan Jin 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009109
What this trial is testing

Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

Who this might be right for
Myeloma, Multiple
Alliance Foundation Trials, LLC. 79
Early research (Phase 1)WithdrawnNCT05513612
What this trial is testing

Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)B-cell Non-Hodgkin's Lymphoma (B-NHL)Multiple Myeloma (MM)+2 more
Shanghai Pudong Hospital
Large-scale testing (Phase 3)UnknownNCT01134484
What this trial is testing

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Michele Cavo 480
Early research (Phase 1)Study completedNCT03762291
What this trial is testing

Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine

Who this might be right for
Multiple Myeloma
Baylor College of Medicine 1
Not applicableLooking for participantsNCT07236502
What this trial is testing

Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Medical College of Wisconsin 184
Next Page